BRIEF published on 07/17/2025 at 15:54, 1 year 1 month ago The Vanguard Group, Inc. Discloses Position on Assura plc Securities Takeover Code Vanguard Group Shareholding Assura Plc
PRESS RELEASE published on 07/17/2025 at 15:53, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.62% ownership in Qualcomm Incorporated as of 16 July 2025. Also making disclosures for Alphawave IP Group plc The Vanguard Group Ownership Disclosure Financial Disclosure Alphawave IP Group Plc Qualcomm Incorporated
BRIEF published on 07/17/2025 at 15:53, 1 year 1 month ago The Vanguard Group Discloses Position in Alphawave IP Group Form 8.3 Takeover Code Securities Disclosure Vanguard Group Alphawave IP
BRIEF published on 07/17/2025 at 15:52, 1 year 1 month ago The Vanguard Group Discloses Position in Deliveroo Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Deliveroo
PRESS RELEASE published on 07/17/2025 at 15:52, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses ownership of 8.35% in American Axle & Manufacturing Holdings, Inc. through Form 8.3 filing Form 8.3 The Vanguard Group Financial Filing Ownership Disclosure American Axle
BRIEF published on 07/17/2025 at 15:52, 1 year 1 month ago The Vanguard Group Discloses Position in Dowlais Group plc Takeover Code Securities Disclosure Vanguard Group Investment Position Dowlais Group
PRESS RELEASE published on 07/17/2025 at 15:52, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses a 3.50% interest in the Dalata Hotel Group plc through Form 8.3 with the Irish Takeover Panel on 16 July 2025 Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Dalata Hotel
BRIEF published on 07/17/2025 at 15:51, 1 year 1 month ago The Vanguard Group Reports Position in Tritax Big Box REIT Form 8.3 Takeover Code Vanguard Group Shareholding Tritax Big Box
PRESS RELEASE published on 07/17/2025 at 15:51, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% stake in Mural Oncology plc as of 16 July 2025. No other party disclosures made. No recent dealings reported The Vanguard Group, Inc. Irish Takeover Panel Financial Disclosure Stake Disclosure Mural Oncology Plc
BRIEF published on 07/17/2025 at 15:50, 1 year 1 month ago The Vanguard Group Discloses Position in Bakkavor Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Bakkavor Group
Published on 09/11/2026 at 21:25, 1 hour 29 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 5 hours 54 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 7 hours 29 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 7 hours 54 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 22:15, 39 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 43 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 9 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 4 hours 38 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 15 hours 54 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 15 hours 54 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
